Abstracts tagged "Sjogren’s syndrome and work"

Abstract Number: 2237 • 2017 ACR/ARHP Annual Meeting
Work Productivity and Activity Impairment in Primary Sjögren’s Syndrome
Marisel Bejarano¹, Anastasia Secco¹, Antonio Catalan Pellet², Marta Mamani³, Silvia Papasidero⁴, Julia Demarchi⁵, Cecilia Asnal⁶, Catherine Crow⁷, Alejandro Nitsche⁸, Laura Encinas⁹, Francisco Caeiro¹⁰, Carla Gobbi¹¹, Eduardo Albiero¹², Andrea Gomez¹³, Juan Carlos Barreira¹⁴, Rodrigo Aguila Maldonado¹⁵, Mercedes Garcia¹⁶, Maria Gallardo¹⁷, Enrique R Soriano¹⁸, Laura Raiti¹⁹, Gabriela Salvatierra²⁰ and Alicia Eimon²¹, ¹Hospital Bernardino Rivadavia, CABA, Argentina, ²Rheumatology, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ³Rheumatology Department, Hospital Bernardino Rivadavia, Buenos Aires, Argentina, ⁴Section of Rheumatology, Hospital General de Agudos “Dr. E. Tornú”, Buenos Aires, Argentina, Buenos Aires, Argentina, ⁵Hospital General de Agudos “Dr. E. Tornú”, CABA, Argentina, ⁶Rheumatology, Hospital Alemán, Buenos Aires, Argentina, ⁷[email protected], Hospital Alemán, Buenos Aires, Argentina, ⁸Hospital Alemán, CABA, Argentina, ⁹Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, ¹⁰Rheumatology, Hospital Privado Centro Médico de Córdoba, Córdoba, Argentina, ¹¹Rheumatology, Hospital Córdoba, Cordoba, Argentina, ¹²Universidad Nacional de Cordoba, Rheumatology Unit Cordoba Hospital, Córdoba, Argentina, ¹³Hospital Britanico de Buenos Aires, CABA, Argentina, ¹⁴Rheumatology Unit, Hospital Británico de Buenos Aires, CABA, Argentina, ¹⁵Rheumatology, HIGA General San Martin La Plata, La Plata, Argentina, ¹⁶Hospital San Martín de la Plata, La Plata, Argentina, ¹⁷Hospital Italiano de Buenos Aires, CABA, Argentina, ¹⁸Argentina, Hospital Italiano de Buenos Aires, Buenos Aires, Argentina, ¹⁹Rheumatology Department, Clinica Bessone, Buenos Aires, Argentina, ²⁰IPRI, Santiago del Estero, Argentina, ²¹CEMIC, Buenos Aires, Argentina
Background/Purpose: To describe the work productivity and activity impairment in adult patients diagnosed with primary Sjögren´s Syndrome (pSS). To evaluate the association between activity impairment…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].